Clinical Trial

Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis

Name: Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis — clinical trial record (NCT07192939)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of HRS-9813 in subjects with pulmonary fibrosis。

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-24.

Status change: Not Yet Recruiting → Recruiting 2025-12-18

Trial Details

NCT Number	NCT07192939
Lead Sponsor	Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions	IPF and PPF
Enrollment	270 participants
Start Date	2025-10-29
Primary Completion	2028-06 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2025-12-24